語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Reviews on New Drug Targets in Age-R...
~
Guest, Paul C.
Reviews on New Drug Targets in Age-Related Disorders = Part II /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Reviews on New Drug Targets in Age-Related Disorders/ edited by Paul C. Guest.
其他題名:
Part II /
其他作者:
Guest, Paul C.
面頁冊數:
VIII, 272 p. 41 illus., 31 illus. in color.online resource. :
Contained By:
Springer Nature eBook
標題:
Bioinformatics. -
電子資源:
https://doi.org/10.1007/978-3-030-55035-6
ISBN:
9783030550356
Reviews on New Drug Targets in Age-Related Disorders = Part II /
Reviews on New Drug Targets in Age-Related Disorders
Part II /[electronic resource] :edited by Paul C. Guest. - 1st ed. 2021. - VIII, 272 p. 41 illus., 31 illus. in color.online resource. - Proteomics, Metabolomics, Interactomics and Systems Biology,12862730-6224 ;. - Proteomics, Metabolomics, Interactomics and Systems Biology,1055.
New Therapeutic Approaches and Biomarkers for Increased Healthspan -- Targeting Cancer Metabolism and Current Anti-Cancer Drugs -- A Review of Monoclonal Antibody-based Treatments in Non-small Cell Lung Cancer -- Parkinson’s Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature -- Targeted Treatment of Age-related Fibromyalgia with Supplemental Coenzyme Q10 -- Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis -- Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer -- A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors -- Towards a New Era for the Management of Circulating Tumor Cells -- Telomerase: A target for Therapeutic Effects of Curcumin in Cancer -- Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence -- Targeting Stem Cells in Chronic Inflammatory Diseases -- Therapeutic Strategies and Nano-drug Delivery Applications in Management of Aging Alzheimer's Disease -- Psychometric Evaluation of Stress in 17,414 Critical Care Unit Nurses: Effects of Age, Gender and Working Conditions -- Targeting Age-related Neurodegenerative Diseases by AAV Mediated Gene Therapy -- Is Adipose Tissue the Fountain of Youth? The impact of Adipose Atem Cell Aging on Metabolic Homeostasis, Longevity and Cell-Based Therapies -- Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders -- Index.
Aging is an inevitable part of life, and is becoming a worldwide social, economic and health problem due to the fact that an increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders. New therapeutic approaches are still in need to decrease or slow the effects of such diseases in this aging society. Advances in ‘omic technologies such as genomics, transcriptomics, proteomics and metabolomics have significantly advanced our understanding of diseases in multiple medical areas. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan, which will in turn lead to new therapeutic strategies and drug development projects by the pharmaceutical industry.This new book presents a series of reviews describing studies which have resulted in the identification of potential new drug targets for age-related disorders. Much of this information has come from ‘omic comparisons of healthy and disease states or from testing the effects of potential new therapeutic approaches. Each chapter will be presented in the context of specific chronic diseases or different therapeutic strategies, providing important information on disease mechanisms related to the aging process. This book will be of interest to researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians, and major drug companies. With contributors from Australia, Brazil, Canada, France, Germany, India, Iran, Iraq, South Africa, South Korea, Thailand, Ukraine, United Kingdom, United States of America,Uruguay and Vietnam, this is a timely follow up to Guest’s previous book Reviews on New Drug Targets in Age-Related Disorders.
ISBN: 9783030550356
Standard No.: 10.1007/978-3-030-55035-6doiSubjects--Topical Terms:
583857
Bioinformatics.
LC Class. No.: QH324.2-324.25
Dewey Class. No.: 570.285
Reviews on New Drug Targets in Age-Related Disorders = Part II /
LDR
:04733nam a22004095i 4500
001
1047963
003
DE-He213
005
20211115194227.0
007
cr nn 008mamaa
008
220103s2021 sz | s |||| 0|eng d
020
$a
9783030550356
$9
978-3-030-55035-6
024
7
$a
10.1007/978-3-030-55035-6
$2
doi
035
$a
978-3-030-55035-6
050
4
$a
QH324.2-324.25
072
7
$a
PSD
$2
bicssc
072
7
$a
SCI056000
$2
bisacsh
072
7
$a
PSD
$2
thema
072
7
$a
UB
$2
thema
082
0 4
$a
570.285
$2
23
245
1 0
$a
Reviews on New Drug Targets in Age-Related Disorders
$h
[electronic resource] :
$b
Part II /
$c
edited by Paul C. Guest.
250
$a
1st ed. 2021.
264
1
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2021.
300
$a
VIII, 272 p. 41 illus., 31 illus. in color.
$b
online resource.
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
347
$a
text file
$b
PDF
$2
rda
490
1
$a
Proteomics, Metabolomics, Interactomics and Systems Biology,
$x
2730-6224 ;
$v
1286
505
0
$a
New Therapeutic Approaches and Biomarkers for Increased Healthspan -- Targeting Cancer Metabolism and Current Anti-Cancer Drugs -- A Review of Monoclonal Antibody-based Treatments in Non-small Cell Lung Cancer -- Parkinson’s Disease and Impairment in Mitochondrial Metabolism: A Pathognomic Signature -- Targeted Treatment of Age-related Fibromyalgia with Supplemental Coenzyme Q10 -- Immunoregulatory Effects of Tolerogenic Probiotics in Multiple Sclerosis -- Multifaceted Roles of Long Non-coding RNAs in Head and Neck Cancer -- A Systematic Review on the Genotoxic Effects of Selective Serotonin Reuptake Inhibitors -- Towards a New Era for the Management of Circulating Tumor Cells -- Telomerase: A target for Therapeutic Effects of Curcumin in Cancer -- Aspirin as a Potential Geroprotector: Experimental Data and Clinical Evidence -- Targeting Stem Cells in Chronic Inflammatory Diseases -- Therapeutic Strategies and Nano-drug Delivery Applications in Management of Aging Alzheimer's Disease -- Psychometric Evaluation of Stress in 17,414 Critical Care Unit Nurses: Effects of Age, Gender and Working Conditions -- Targeting Age-related Neurodegenerative Diseases by AAV Mediated Gene Therapy -- Is Adipose Tissue the Fountain of Youth? The impact of Adipose Atem Cell Aging on Metabolic Homeostasis, Longevity and Cell-Based Therapies -- Proteomics for Target Identification in Psychiatric and Neurodegenerative Disorders -- Index.
520
$a
Aging is an inevitable part of life, and is becoming a worldwide social, economic and health problem due to the fact that an increasing proportion of individuals in the advanced age category have a higher probability of developing age-related disorders. New therapeutic approaches are still in need to decrease or slow the effects of such diseases in this aging society. Advances in ‘omic technologies such as genomics, transcriptomics, proteomics and metabolomics have significantly advanced our understanding of diseases in multiple medical areas. It is hoped that emerging hits from these analyses might be prioritized for further screening as potential novel drug targets for increasing the human healthspan in line with the lifespan, which will in turn lead to new therapeutic strategies and drug development projects by the pharmaceutical industry.This new book presents a series of reviews describing studies which have resulted in the identification of potential new drug targets for age-related disorders. Much of this information has come from ‘omic comparisons of healthy and disease states or from testing the effects of potential new therapeutic approaches. Each chapter will be presented in the context of specific chronic diseases or different therapeutic strategies, providing important information on disease mechanisms related to the aging process. This book will be of interest to researchers in the areas of aging and chronic disease, as well as clinical scientists, physicians, and major drug companies. With contributors from Australia, Brazil, Canada, France, Germany, India, Iran, Iraq, South Africa, South Korea, Thailand, Ukraine, United Kingdom, United States of America,Uruguay and Vietnam, this is a timely follow up to Guest’s previous book Reviews on New Drug Targets in Age-Related Disorders.
650
0
$a
Bioinformatics.
$3
583857
650
0
$a
Genetics.
$3
578972
650
0
$a
Biochemistry.
$3
582831
650
2 4
$a
Genetics and Genomics.
$3
1229010
650
2 4
$a
Biochemistry, general.
$3
593881
700
1
$a
Guest, Paul C.
$4
edt
$4
http://id.loc.gov/vocabulary/relators/edt
$3
1139505
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer Nature eBook
776
0 8
$i
Printed edition:
$z
9783030550349
776
0 8
$i
Printed edition:
$z
9783030550363
830
0
$a
Proteomics, Metabolomics, Interactomics and Systems Biology,
$x
2730-6216 ;
$v
1055
$3
1285713
856
4 0
$u
https://doi.org/10.1007/978-3-030-55035-6
912
$a
ZDB-2-SBL
912
$a
ZDB-2-SXB
950
$a
Biomedical and Life Sciences (SpringerNature-11642)
950
$a
Biomedical and Life Sciences (R0) (SpringerNature-43708)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入